Novel and Re-emerging Respiratory Viral Diseases: Novartis Foundation Symposium 290
نویسندگان
چکیده
منابع مشابه
Novel and Re-emerging Respiratory Viral Diseases: Novartis Foundation Symposium 290
At of end his book, John Parascandola writes, “It is my hope that the reader ... acquired a broader appreciation of disease as a social as well as a medical construct and of the way in which social and cultural factors influence our understanding of and reaction to any given disease.” The social context of syphilis is nicely summarized by the title, Sex, Sin, and Science: A History of Syphilis ...
متن کاملEmerging and re-emerging viral diseases: risks and controls
In the present globalized world with overflowing travels and trades, human health has been increasingly threatened due to incidences of emerging or/and re-emerging infectious diseases. The most important sources of novel human pathogens are mainly farm mammals and poultry, and to some extent, wild animals and arthropods. It is estimated that zoonosis constitute about 60% of the ‘known’, and up ...
متن کاملEmerging and Re-emerging Viral Diseases of Small Animals
The newest emerging viral infection of dogs is canine circovirus. It was thought to be the cause of illness and mortality in Ohio dogs in late August/early September 2013. Canine circovirus can either be the primary infection or present in the form of co-infection with other enteric pathogens. Its role as a primary pathogen still needs to be defined. In a recent paper, Linlin et al (1) document...
متن کاملEmerging and Re-emerging Viral Diseases of Large Animals
A single-nucleotide polymorphism (A(2254) or G(2254)) in the DNA polymerase gene of equine herpesvirus 1 (EHV-1) has been linked to the neuropathogenic phenotype which induces equine herpes myeloencephalitis (EHM). Based upon this, a real-time PCR assay to distinguish potentially neuropathogenic from non-neuropathogenic EHV-1 strains was described in 2007. With some limitations, this assay was ...
متن کاملThe Novartis Foundation
before — a hotbed of gene therapy research. It was a remarkable opportunity. Mulligan was offered one laboratory at the Children's Hospital to work on the basic science of viral vectors, and a second laboratory in a central Harvard building that will manufacture the vectors for use in human trials. Despite all these enticements, Mulligan did not agree to move — and leave a position at the White...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Emerging Infectious Diseases
سال: 2009
ISSN: 1080-6040,1080-6059
DOI: 10.3201/eid1506.090293